benzydamine hydrochloride
benzydamine hydrochloride is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Benzydamine for Radiation-Induced Oral Mucositis in Patients Receiving High-Dose Radiotherapy
Benzydamine Hydrochloride and Post-operative Sore Throat
Preoperative Aspirin and Benzydamine Hydrochloride Gargles on Severity and Duration of Post-Operative Sore Throat
The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy
Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
Clinical Trials (6)
Benzydamine for Radiation-Induced Oral Mucositis in Patients Receiving High-Dose Radiotherapy
Benzydamine Hydrochloride and Post-operative Sore Throat
Preoperative Aspirin and Benzydamine Hydrochloride Gargles on Severity and Duration of Post-Operative Sore Throat
The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy
Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
Effect of Benzydamine Hydrochloride to Postoperative Sore Throat in Pediatric Patients
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6